Long-term evidence found all patients treated with Evoke were “clinically significant responders in at least one outcome measure of pain relief, function, sleep, quality of life, or mood,” according to a July 19 news release. One in two Evoke patients also saw a holistic outcome response.
The Evoke system is the only smart spinal cord stimulator that senses and measures responses to stimulation, according to Saluda Medical. It can adjust therapy more than 4 million times daily for chronic pain patients.
The study, published in Pain, can be read here.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.